DAM
MRK icon

Deimos Asset Management’s Merck MRK Stock Holding History

Deimos Asset Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-5,240
Closed -$265K – 112
2016
Q1 		$265K Buy
+5,240
New +$257K 0.19% 97

Other funds holding MRK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Deimos Asset Management's MRK Position: Q2 2016 in Review

Deimos Asset Management sold out of Merck (MRK) in Q2 2016, closing a stake of 5,240 shares — an estimated $265K sold.

Deimos Asset Management first reported a position in MRK in Q1 2016 and held it in 1 quarter. The position peaked at $265K in Q1 2016. 1,761 funds tracked by Wall St. Rank hold MRK as of Q2 2016.

  • Deimos Asset Management reported no remaining Merck position as of Q2 2016 after selling out during the quarter.
  • Deimos Asset Management sold 5,240 Merck shares in Q2 2016, an estimated $265K.
  • Deimos Asset Management first reported a position in Merck in Q1 2016 and held it in 1 quarter.
  • Deimos Asset Management's Merck position peaked at $265K in Q1 2016.
  • 1,761 funds tracked by Wall St. Rank held Merck as of Q2 2016.

Based on Deimos Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.